Advanced in Jock Itch

Dr. Lawrence Parish

Dermatology
Office
1845 Walnut St Ste 1650, 
Philadelphia, PA 
Clinical Trials:Currently Recruiting for 1 Trial
Advanced in Jock Itch
Office
1845 Walnut St Ste 1650, 
Philadelphia, PA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Lawrence Parish is a Dermatologist in Philadelphia, Pennsylvania. Dr. Parish is rated as an Advanced provider by MediFind in the treatment of Jock Itch. His top areas of expertise are Hartnup Disease, Athlete's Foot, St. Anthony's Fire, and Contact Dermatitis.

His clinical research consists of co-authoring 187 peer reviewed articles and participating in 12 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Jock Itch.

Specialties
Dermatology
Licenses
Dermatology in PA
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Aspirus Arise Health Plan
  • INSURANCE PLAN
  • OTHER COMMERCIAL
Avalon Health Care
  • MEDICARE PDP
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Geisinger
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Partners Plans
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
Highmark
  • EPO
  • HMO
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
PA Health and Wellness
  • HMO
  • MANAGED MEDICAID PLAN
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
UPMC
  • EPO
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 16 Less Insurance Carriers -

Locations

Office
1845 Walnut St Ste 1650, Philadelphia, PA 19103
Call: 215-563-8333

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

12 Clinical Trials

A Single Treatment Pharmacokinetic and Safety Study of Natroba (Spinosad) Topical Suspension 0.9% w/w in Subjects 1 Month to 3 Years 11 Months of Age With an Active Scabies Infestation
A Single Treatment Pharmacokinetic and Safety Study of Natroba (Spinosad) Topical Suspension 0.9% w/w in Subjects 1 Month to 3 Years 11 Months of Age With an Active Scabies Infestation
Enrollment Status: Recruiting
Publish Date: February 14, 2025
Intervention Type: Drug
Study Phase: Phase 4
A Long-term Study to Assess the Safety and Efficacy of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis (ADjoin)
A Long-term Study to Assess the Safety and Efficacy of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis (ADjoin)
Enrollment Status: Completed
Publish Date: November 05, 2025
Intervention Type: Biological
Study Drug: Lebrikizumab
Study Phase: Phase 3
A Phase Ib, Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study of the Clinical Effect, Safety and Tolerability of a Single Intravenous Infusion of GSK1070806 in Moderate to Severe Atopic Dermatitis Patients
A Phase Ib, Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study of the Clinical Effect, Safety and Tolerability of a Single Intravenous Infusion of GSK1070806 in Moderate to Severe Atopic Dermatitis Patients
Enrollment Status: Completed
Publish Date: August 28, 2025
Intervention Type: Drug
Study Drug: GSK1070806
Study Phase: Phase 1
A Phase 1, Double-Blind, Randomized, Placebo-Controlled, Multiple-Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Subcutaneous LY3471851 in Patients With Psoriasis
A Phase 1, Double-Blind, Randomized, Placebo-Controlled, Multiple-Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Subcutaneous LY3471851 in Patients With Psoriasis
Enrollment Status: Completed
Publish Date: February 20, 2024
Intervention Type: Drug
Study Drug: LY3471851
Study Phase: Phase 1
A Phase 1, Double-Blind, Randomized, Placebo-Controlled, Multiple-Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Subcutaneous LY3471851 in Patients With Atopic Dermatitis
A Phase 1, Double-Blind, Randomized, Placebo-Controlled, Multiple-Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Subcutaneous LY3471851 in Patients With Atopic Dermatitis
Enrollment Status: Completed
Publish Date: February 20, 2024
Intervention Type: Drug
Study Drug: NKTR-358
Study Phase: Phase 1
Topical Ruxolitinib Evaluation in Atopic Dermatitis Study 2 (TRuE AD2) - A Phase 3, Double-Blind, Randomized, 8-Week, Vehicle-Controlled Efficacy and Safety Study of Ruxolitinib Cream Followed by a Long-Term Safety Extension Period in Adolescents and Adults With Atopic Dermatitis
Topical Ruxolitinib Evaluation in Atopic Dermatitis Study 2 (TRuE AD2) - A Phase 3, Double-Blind, Randomized, 8-Week, Vehicle-Controlled Efficacy and Safety Study of Ruxolitinib Cream Followed by a Long-Term Safety Extension Period in Adolescents and Adults With Atopic Dermatitis
Enrollment Status: Completed
Publish Date: September 28, 2023
Intervention Type: Drug
Study Phase: Phase 3
An Open-Label, Single-Arm Study to Assess the Safety and Efficacy of Lebrikizumab in Adolescent Patients With Moderate-to-Severe Atopic Dermatitis
An Open-Label, Single-Arm Study to Assess the Safety and Efficacy of Lebrikizumab in Adolescent Patients With Moderate-to-Severe Atopic Dermatitis
Enrollment Status: Completed
Publish Date: February 24, 2023
Intervention Type: Biological
Study Drug: Lebrikizumab
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled Phase II Study to Evaluate Efficacy, Pharmacokinetics, and Safety of Multiple Intravenous Doses of FB825 in Adults With Atopic Dermatitis
A Randomized, Double-Blind, Placebo-Controlled Phase II Study to Evaluate Efficacy, Pharmacokinetics, and Safety of Multiple Intravenous Doses of FB825 in Adults With Atopic Dermatitis
Enrollment Status: Unknown
Publish Date: April 04, 2022
Intervention Type: Biological, Other
Study Drug: FB825
Study Phase: Phase 2
A Phase I/II Clinical Trial of Topical KB105, a Replication-incompetent, Non-integrating HSV-1 Vector Expressing Human Transglutaminase 1 (TGM1) for the Treatment of TGM1-deficient Autosomal Recessive Congenital Ichthyosis (ARCI)
A Phase I/II Clinical Trial of Topical KB105, a Replication-incompetent, Non-integrating HSV-1 Vector Expressing Human Transglutaminase 1 (TGM1) for the Treatment of TGM1-deficient Autosomal Recessive Congenital Ichthyosis (ARCI)
Enrollment Status: Unknown
Publish Date: September 13, 2021
Intervention Type: Biological
Study Drug: KB105
Study Phase: Phase 1/Phase 2
Open-Label Study of the Pharmacokinetics and Safety Including HPA Axis Suppression Potential of Clobetasol Topical Oil in Pediatric Subjects With Moderate to Severe Atopic Dermatitis
Open-Label Study of the Pharmacokinetics and Safety Including HPA Axis Suppression Potential of Clobetasol Topical Oil in Pediatric Subjects With Moderate to Severe Atopic Dermatitis
Enrollment Status: Terminated
Publish Date: June 23, 2021
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
A Phase 3, Randomized, Double Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Natroba™ (Spinosad) for the Treatment of Scabies
A Phase 3, Randomized, Double Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Natroba™ (Spinosad) for the Treatment of Scabies
Enrollment Status: Completed
Publish Date: May 21, 2021
Intervention Type: Other, Drug
Study Phase: Phase 3
A Double-Blind, Randomized, Placebo-Controlled Dose-Ranging Study Evaluating the Efficacy and Safety of Once Weekly High Dose Oral Finasteride in the Treatment of Severe Nodulocystic Acne
A Double-Blind, Randomized, Placebo-Controlled Dose-Ranging Study Evaluating the Efficacy and Safety of Once Weekly High Dose Oral Finasteride in the Treatment of Severe Nodulocystic Acne
Enrollment Status: Completed
Publish Date: February 15, 2019
Intervention Type: Drug
Study Phase: Phase 2
View 11 Less Clinical Trials

187 Total Publications

Red Marble and the Art for Peace. An Example from the Great Northern Wars (1700-1772).
Red Marble and the Art for Peace. An Example from the Great Northern Wars (1700-1772).
Journal: Clinics in dermatology
Published: October 30, 2025
View All 187 Publications
Similar Doctors
Distinguished in Jock Itch
Dr. Jennifer Parish
Dermatology
Distinguished in Jock Itch
Dr. Jennifer Parish
Dermatology

Office

1845 Walnut St Ste 1650, 
Philadelphia, PA 
 (0.2 miles away)
215-563-8333
Languages Spoken:
English
See accepted insurances

Jennifer Parish is a Dermatologist in Philadelphia, Pennsylvania. Dr. Parish is rated as a Distinguished provider by MediFind in the treatment of Jock Itch. Her top areas of expertise are Jock Itch, Athlete's Foot, Perioral Dermatitis, and Sunburn.

Advanced in Jock Itch
Dr. Harold H. Weiss
Dermatology
Advanced in Jock Itch
Dr. Harold H. Weiss
Dermatology

Steven M Weissman MD, LLC

27 South Cooks Bridge Road, Suite 2-14, 
Jackson, NJ 
 (20.3 miles away)
Languages Spoken:
English
See accepted insurances

Harold Weiss is a Dermatologist in Jackson, New Jersey. Dr. Weiss is rated as a Distinguished provider by MediFind in the treatment of Jock Itch. His top areas of expertise are Athlete's Foot, Contact Dermatitis, Comedones, and Jock Itch.

Advanced in Jock Itch
Dr. Alissa Fox
Dermatology
Advanced in Jock Itch
Dr. Alissa Fox
Dermatology

Hillsborough Women's Health

3461 US Highway 22, 
Branchburg, NJ 
 (51.5 miles away)
908-725-4777
Languages Spoken:
English
See accepted insurances

Alissa Fox is a Dermatologist in Branchburg, New Jersey. Dr. Fox is rated as a Distinguished provider by MediFind in the treatment of Jock Itch. Her top areas of expertise are Neurocutaneous Melanosis, Giant Congenital Nevus, Giant Congenital Melanocytic Nevus, and Familial Atypical Multiple Mole Melanoma Syndrome.

VIEW MORE JOCK ITCH DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Parish's expertise for a condition
ConditionClose
    • Distinguished
    • Athlete's Foot
      Dr. Parish is
      Distinguished
      . Learn about Athlete's Foot.
      See more Athlete's Foot experts
    • Contact Dermatitis
      Dr. Parish is
      Distinguished
      . Learn about Contact Dermatitis.
      See more Contact Dermatitis experts
    • Hartnup Disease
      Dr. Parish is
      Distinguished
      . Learn about Hartnup Disease.
      See more Hartnup Disease experts
    • St. Anthony's Fire
      Dr. Parish is
      Distinguished
      . Learn about St. Anthony's Fire.
      See more St. Anthony's Fire experts
    • Advanced
    • Atopic Dermatitis
      Dr. Parish is
      Advanced
      . Learn about Atopic Dermatitis.
      See more Atopic Dermatitis experts
    • Bannayan-Riley-Ruvalcaba Syndrome
      Dr. Parish is
      Advanced
      . Learn about Bannayan-Riley-Ruvalcaba Syndrome.
      See more Bannayan-Riley-Ruvalcaba Syndrome experts
    • Buschke-Ollendorff Syndrome
      Dr. Parish is
      Advanced
      . Learn about Buschke-Ollendorff Syndrome.
      See more Buschke-Ollendorff Syndrome experts
    • Cherry Angioma
      Dr. Parish is
      Advanced
      . Learn about Cherry Angioma.
      See more Cherry Angioma experts
    • Comedones
      Dr. Parish is
      Advanced
      . Learn about Comedones.
      See more Comedones experts
    • Cowden Syndrome
      Dr. Parish is
      Advanced
      . Learn about Cowden Syndrome.
      See more Cowden Syndrome experts
    View All 29 Advanced Conditions
    • Experienced
    • Acanthosis Nigricans
      Dr. Parish is
      Experienced
      . Learn about Acanthosis Nigricans.
      See more Acanthosis Nigricans experts
    • Acne
      Dr. Parish is
      Experienced
      . Learn about Acne.
      See more Acne experts
    • Acquired Ichthyosis
      Dr. Parish is
      Experienced
      . Learn about Acquired Ichthyosis.
      See more Acquired Ichthyosis experts
    • Acrospiroma
      Dr. Parish is
      Experienced
      . Learn about Acrospiroma.
      See more Acrospiroma experts
    • Actinic Keratosis
      Dr. Parish is
      Experienced
      . Learn about Actinic Keratosis.
      See more Actinic Keratosis experts
    • Alopecia Totalis
      Dr. Parish is
      Experienced
      . Learn about Alopecia Totalis.
      See more Alopecia Totalis experts
    View All 64 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2026 All Rights Reserved

      Request an Appointment

      If you are experiencing a medical emergency, call 9-1-1.

      MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

      Patient Details

      This information is for the patient who will be seen at the appointment.

        Close

        Returning patient? Use your address on file with the provider.

        Insurance Details

        Please provide information of the primary insurance holder as the practice may require this information to schedule.

        Insurance Provider *
        Insurance ProviderClose

        Appointments Details

        Let’s get more information about your appointment.

                0 / 1000
                0 / 1000
                By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.